Profuse oral secretions after propafenone administration in neonates

Research output: Contribution to journalArticlepeer-review


Propafenone, an antiarrhythmic drug that is effective for treating supraventricular tachycardias, can induce well-known proarrhythmic and systemic adverse effects. We describe a previously unreported adverse effect in 3 newborns: oral propafenone-induced profuse oral secretions and respiratory distress of sufficient severity to necessitate discontinuation of propafenone.

Original languageEnglish
Pages (from-to)856-857
Number of pages2
JournalJournal of Pediatrics
Issue number5
Publication statusPublished - Nov 2010


  • ECG
  • Electrocardiogram
  • Supraventricular tachycardia
  • SVT

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Fingerprint Dive into the research topics of 'Profuse oral secretions after propafenone administration in neonates'. Together they form a unique fingerprint.

Cite this